Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Reference52 articles.
1. EMA. EPAR summary for the public. Valdoxan (agomelatine). London: European Medicines Agency 2013.
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000915/WC500046224.pdf
. Accessed 11 Feb 2019.
2. Les Laboratoires Servier. Valdoxan summary of product characteristics. 2016.
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000915/WC500046227.pdf
. Accessed 11 Feb 2019.
3. Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 2014;171(4):404–15.
4. Park SH, Ishino R. Liver injury associated with antidepressants. Curr Drug Saf. 2013;8(3):207–23.
5. Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806–15.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献